Del Carlo cross strap sandals sale for sale outlet big discount outlet browse eAk4bk

SKU-5256814594
Del Carlo cross strap sandals sale for sale outlet big discount outlet browse eAk4bk
Del Carlo cross strap sandals
Beginning of Message Box Michel Vivien flat sandals supply cheap online 2GYnDOMz

It seems you're using a browser version we no longer support. To get the best online experience, please consider upgrading to one of the following newer browsers.

Mara Mac panelled peep toe footlocker finishline sale online clearance get to buy outlet best store to get PqNnZM9
Divalicious Leopard low shipping fee sale online cheap explore sale shop offer 6WaP3vtDpy
Simply Vera Vera Wang Dumplings Womens High Heels free shipping 100% authentic sale online hot sale cheap price for nice sale online discount outlet locations ZcbZpPJlyG
Malone Souliers Maureen stiletto heel mules outlet the cheapest gcCG2r
South Beach Black Cross Front Slides cheap best 2014 unisex online qxt7FLH8C
DESIGN Algebra leather lace up boots extremely cheap online O6rUp
cheap 2014 Dolce Vita fringe flat sandals websites sale online new styles outlet order online 4go2HUe2A0
outlet discount authentic fake cheap price Unionbay Boa Womens Slide Sandals buy cheap reliable free shipping 2014 unisex cheap from china jUt3N7zm
Register new styles for sale nicekicks for sale Aquazzura Brown Suede Downtown 90 Ankle Boots ZjeW2QKY2
Nike SOULLAND x Nike SB Zoom Dunk Low Pro QS sneakers free shipping discount agAuePq
Français

Topline results from the first of three Phase 3 trials in psoriasis clinical development program

Share
| Source: Dermira, Inc.

BRUSSELS, Belgium and MENLO PARK, Calif., Oct. 03, 2016 (GLOBE NEWSWIRE) -- UCB (Euronext:UCB) and Dermira, Inc. (NASDAQ:) today announced topline results from CIMPASI-2, a Phase 3, multi-center, placebo-controlled clinical trial evaluating the efficacy and safety of CIMZIA® (certolizumab pegol) in adult patients with moderate-to-severe chronic plaque psoriasis. In the CIMPASI-2 trial, CIMZIA demonstrated statistically significant improvements for both co-primary endpoints compared to placebo at both treatment doses. The CIMPASI-2 trial results are from the first of three Phase 3 clinical trials to be reported evaluating CIMZIA in this patient population. 1

The co-primary endpoints evaluated in the trial were the percentage of patients who achieved a 75% or greater disease improvement from baseline as measured by the Psoriasis Area and Severity Index (PASI 75) and the percentage of patients achieving at least a two-point improvement on a five-point Physician’s Global Assessment (PGA) scale to a final score representing clear or almost clear skin, each compared with placebo, at week 16. 1

A total of 227 patients with moderate-to-severe chronic plaque psoriasis were randomized to three dosing arms—400 mg every two weeks (n=87), 400 mg at weeks 0, 2, and 4 followed by 200 mg every two weeks (n=91), or placebo every two weeks (n=49). At week 16, the response rate for patients who achieved a PASI 75 was 82.6% for patients receiving the 400 mg dose every two weeks and 81.4% for patients receiving the 200 mg dose every two weeks, compared to 11.6% for patients receiving placebo. The response rate for patients achieving at least a two-point improvement to a final score of clear or almost clear skin on the PGA scale at week 16 was 71.6% for the 400 mg dose-treated patients and 66.8% for the 200 mg dose-treated patients, compared to 2.0% for the patients receiving placebo. CIMZIA demonstrated statistically significant improvements from baseline to week 16 relative to placebo for both co-primary endpoints at both treatment doses. The adverse event profile appears consistent with the adverse event profiles observed with CIMZIA in other indications. 1

“The clinical results from the CIMPASI-2 trial are very encouraging and reinforce our belief that CIMZIA may provide clinically meaningful benefit for moderate-to-severe plaque psoriasis patients,” said Tom Wiggans, chairman and chief executive officer of Dermira. “We look forward to data from the two additional ongoing Phase 3 clinical trials, which are expected by the end of the first quarter of 2017.”

Limited time offer: Use code 'FLYJULY18' for 3 months of FREE hosting!

Limited time offer:
with credit card cheap price Maison Margiela cutout cowboy boots under online free shipping best store to get big sale cheap price sast online 6KIMhmXhW

Never share passwords or create multiple logins again

•••

Streamline your collaboration process

You know you’ve done it — you’ve totally built a spreadsheet with all your client passwords in one place. Flywheel does away with all that. Collaborate easily and instantly with your team without the clunkiness of sharing and storing (and losing. And recovering) passwords.

Fifty and Fifty spends more time building client projects and zero time managing servers

Bryan Monzon is the vice president of engineering at Fifty and Fifty, a company that works on digital products (small and large) for social good. Since starting on Flywheel, Fifty and Fifty have sped up their project complete time and eliminated workflow headaches along the way.

DOWNLOAD

Ditch the spreadsheet filled with passwords. Never ask a client for a password again. Collaborators on Flywheel log in with their own usernames and passwords. They can view and manage all their sites in one place.

Add teammates and clients as collaborators, and they’ll get full access to manage the site, update files, and manage the database.

•••

It’s okay to fall in love with your Flywheel dashboard. Look how pretty it is, showing all the sites you own right next to the ones where you’re a collaborator. With just one login, you can manage all your sites, upload files via SFTP, and modify databases.

When the project is over, remove access from people who don’t need it anymore, and voilà! No more access.

Nike Benassi Solarsoft Sliders In Black 705474070 buy cheap limited edition enjoy sale online outlet popular cheap price cost 44YDhh

Wyman Projects uses Flywheel to centralize their workflow

Nº21 pointed toe sandals outlet cost I2Rx7V

Try it yourself. It's free takes less than 60 seconds. SIGN UP

Reimagined SFTP

You know you’ve done it – a spreadsheet with all your client passwords in one place. Flywheel frees you from the need to share and store passwords.

Learn More
•••
•••

Test out changes in a test enviroment and easily push to production.

Sleep soundly at night knowing that all your important files are backed up nightly.

When you're done developing, easily transfer a site to your client for payment.

Powerful Tools

Managed Hosting

We'd love hearing from you. Give us a call and we can chat about your needs.

See for yourself how Flywheel can make your life easier.

© GG.COM 2018 | A2 by Aerosoles Yet Around Womens Wedge Sandals nicekicks NJ81M3LR6
18+
v5.31.1 | Served in 0.21s by frontend-03